New cholesterol-lowering drugs are discussed by UB cardiologist and researcher
The new statin alternatives, the class of drugs known as PCSK9 inhibitors, which are just coming onto the market, are a welcome addition for treating high cholesterol, said Stanley F. Fernandez, MD, PhD, assistant professor ...
Sep 9, 2015
0
6